Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
Neutralizing antibodies (NAbs) to multiple epitopes on the HIV-1-envelope glycoprotein (Env) have been isolated from infected persons. The potency of NAbs is measured more often than the size of the persistent fraction of infectivity at maximum neutralization, which may also influence preventive eff...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-10-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1011601 |
| _version_ | 1826938210581741568 |
|---|---|
| author | Rajesh P Ringe Philippe Colin Gabriel Ozorowski Joel D Allen Anila Yasmeen Gemma E Seabright Jeong Hyun Lee Aleksandar Antanasijevic Kimmo Rantalainen Thomas Ketas John P Moore Andrew B Ward Max Crispin P J Klasse |
| author_facet | Rajesh P Ringe Philippe Colin Gabriel Ozorowski Joel D Allen Anila Yasmeen Gemma E Seabright Jeong Hyun Lee Aleksandar Antanasijevic Kimmo Rantalainen Thomas Ketas John P Moore Andrew B Ward Max Crispin P J Klasse |
| author_sort | Rajesh P Ringe |
| collection | DOAJ |
| description | Neutralizing antibodies (NAbs) to multiple epitopes on the HIV-1-envelope glycoprotein (Env) have been isolated from infected persons. The potency of NAbs is measured more often than the size of the persistent fraction of infectivity at maximum neutralization, which may also influence preventive efficacy of active or passive immunization and the therapeutic outcome of the latter. Many NAbs neutralize HIV-1 CZA97.012, a clone of a Clade-C isolate, to ~100%. But here NAb PGT151, directed to a fusion-peptide epitope, left a persistent fraction of 15%. NAb PGT145, ligating the Env-trimer apex, left no detectable persistent fraction. The divergence in persistent fractions was further analyzed by depletion of pseudoviral populations of the most PGT151- and PGT145-reactive virions. Thereby, neutralization by the non-depleting NAb increased, whereas neutralization by the depleting NAb decreased. Furthermore, depletion by PGT151 increased sensitivity to autologous neutralization by sera from rabbits immunized with soluble native-like CZA97.012 trimer: substantial persistent fractions were reduced. NAbs in these sera target epitopes comprising residue D411 at the V4-β19 transition in a defect of the glycan shield on CZA97.012 Env. NAb binding to affinity-fractionated soluble native-like CZA97.012 trimer differed commensurately with neutralization in analyses by ELISA and surface plasmon resonance. Glycan differences between PGT151- and PGT145-purified trimer fractions were then demonstrated by mass spectrometry, providing one explanation for the differential antigenicity. These differences were interpreted in relation to a new structure at 3.4-Å resolution of the soluble CZA97.012 trimer determined by cryo-electron microscopy. The trimer adopted a closed conformation, refuting apex opening as the cause of reduced PGT145 binding to the PGT151-purified form. The evidence suggests that differences in binding and neutralization after trimer purification or pseudovirus depletion with PGT145 or PGT151 are caused by variation in glycosylation, and that some glycan variants affect antigenicity through direct effects on antibody contacts, whereas others act allosterically. |
| first_indexed | 2024-03-08T03:10:51Z |
| format | Article |
| id | doaj.art-7568988b535a466f9fbb76d93f1b2ea9 |
| institution | Directory Open Access Journal |
| issn | 1553-7366 1553-7374 |
| language | English |
| last_indexed | 2025-02-17T18:53:09Z |
| publishDate | 2023-10-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj.art-7568988b535a466f9fbb76d93f1b2ea92024-12-11T05:31:19ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742023-10-011910e101160110.1371/journal.ppat.1011601Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.Rajesh P RingePhilippe ColinGabriel OzorowskiJoel D AllenAnila YasmeenGemma E SeabrightJeong Hyun LeeAleksandar AntanasijevicKimmo RantalainenThomas KetasJohn P MooreAndrew B WardMax CrispinP J KlasseNeutralizing antibodies (NAbs) to multiple epitopes on the HIV-1-envelope glycoprotein (Env) have been isolated from infected persons. The potency of NAbs is measured more often than the size of the persistent fraction of infectivity at maximum neutralization, which may also influence preventive efficacy of active or passive immunization and the therapeutic outcome of the latter. Many NAbs neutralize HIV-1 CZA97.012, a clone of a Clade-C isolate, to ~100%. But here NAb PGT151, directed to a fusion-peptide epitope, left a persistent fraction of 15%. NAb PGT145, ligating the Env-trimer apex, left no detectable persistent fraction. The divergence in persistent fractions was further analyzed by depletion of pseudoviral populations of the most PGT151- and PGT145-reactive virions. Thereby, neutralization by the non-depleting NAb increased, whereas neutralization by the depleting NAb decreased. Furthermore, depletion by PGT151 increased sensitivity to autologous neutralization by sera from rabbits immunized with soluble native-like CZA97.012 trimer: substantial persistent fractions were reduced. NAbs in these sera target epitopes comprising residue D411 at the V4-β19 transition in a defect of the glycan shield on CZA97.012 Env. NAb binding to affinity-fractionated soluble native-like CZA97.012 trimer differed commensurately with neutralization in analyses by ELISA and surface plasmon resonance. Glycan differences between PGT151- and PGT145-purified trimer fractions were then demonstrated by mass spectrometry, providing one explanation for the differential antigenicity. These differences were interpreted in relation to a new structure at 3.4-Å resolution of the soluble CZA97.012 trimer determined by cryo-electron microscopy. The trimer adopted a closed conformation, refuting apex opening as the cause of reduced PGT145 binding to the PGT151-purified form. The evidence suggests that differences in binding and neutralization after trimer purification or pseudovirus depletion with PGT145 or PGT151 are caused by variation in glycosylation, and that some glycan variants affect antigenicity through direct effects on antibody contacts, whereas others act allosterically.https://doi.org/10.1371/journal.ppat.1011601 |
| spellingShingle | Rajesh P Ringe Philippe Colin Gabriel Ozorowski Joel D Allen Anila Yasmeen Gemma E Seabright Jeong Hyun Lee Aleksandar Antanasijevic Kimmo Rantalainen Thomas Ketas John P Moore Andrew B Ward Max Crispin P J Klasse Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. PLoS Pathogens |
| title | Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. |
| title_full | Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. |
| title_fullStr | Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. |
| title_full_unstemmed | Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. |
| title_short | Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. |
| title_sort | glycan heterogeneity as a cause of the persistent fraction in hiv 1 neutralization |
| url | https://doi.org/10.1371/journal.ppat.1011601 |
| work_keys_str_mv | AT rajeshpringe glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT philippecolin glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT gabrielozorowski glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT joeldallen glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT anilayasmeen glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT gemmaeseabright glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT jeonghyunlee glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT aleksandarantanasijevic glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT kimmorantalainen glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT thomasketas glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT johnpmoore glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT andrewbward glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT maxcrispin glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization AT pjklasse glycanheterogeneityasacauseofthepersistentfractioninhiv1neutralization |